Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer

AKM Claessens, FLG Erdkamp, M Lopez-Yurda, JM Bouma, JM Rademaker-Lakhai, AH Honkoop, H de Graaf, VC Tjan-Heijnen, Monique Bos

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
21 Downloads (Pure)
Original languageEnglish
Pages (from-to)713-722
Number of pages10
JournalActa Oncologica
Issue number6
Publication statusPublished - 2020

Research programs

  • EMC OR-01

Cite this